Weight-loss jabs could help obese people control asthma, study suggests
The drugs should be explored as a potential treatment for obese people with the respiratory condition, who are 'often resistant' to steroids, researchers said.
Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicing the hormone GLP-1 to regulate blood sugar and insulin levels.
They were initially developed as a treatment for people with type 2 diabetes.
A number of types of the drug are recommended to help tackle obesity on the NHS, including semaglutide, or Wegovy, and tirzepatide, or Mounjaro.
Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international team of experts exploring their potential impact on obese people with asthma.
Professor David Price, University of Aberdeen chair in primary care respiratory medicine, said: 'People with obesity and asthma are unique in that they are often resistant to steroid treatments.
'We know that GLP1s work on inflammatory responses in the airways in a different way to traditionally used steroids.'
For the study, published in Advances in Therapy, researchers analysed the records of 10,111 people on GLP1-RAs and 50,555 people who were not on the drugs.
After a follow-up period, the team found that those taking weight-loss jabs lost more weight and had improved asthma control.
Researchers said the findings suggest medics 'should pay attention to the relationship between GLP-1 RA and the risk of respiratory diseases'.
Prof Price added: 'We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms.
'In addition, it is important to note that the benefits to asthma symptoms occurred despite fairly modest weight loss of around 0.9kg over the course of the year.
'Our findings suggest that GLP1s may have beneficial effects on asthma control for people with obesity and this should be explored further.'
Prof Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, said: 'Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs.'
Dr Erika Kennington, head of research and innovation at Asthma and Lung UK, said: 'Research has previously shown that people living with obesity who lose weight see improved control of their asthma, so it's encouraging to see this study show this is still the case when the weight loss is driven by drugs, like the new class of weight loss drugs.
'Although exercise can help people lose weight, for some people it can cause anxiety about becoming breathless or having an asthma attack, so people are stuck in a vicious cycle of not being able to lose weight and their asthma worsening.
'Therefore, where exercise hasn't worked for someone these drugs that support weight loss could offer a promising alternative.
'It's too early to say whether these drugs would be effective for people with asthma more widely.
'More research is needed to understand how these drugs actually improve asthma control. Funding for lung health research is on life support and urgent action is needed to increase investment.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
44 minutes ago
- Business Wire
Instem Announces Acquisition of RockStep Solutions, Inc.
BOSTON & STAFFORDSHIRE, England--(BUSINESS WIRE)--Instem is excited to announce that as of today it has closed on an acquisition of RockStep Solutions. RockStep is the provider of Climb™, a cloud-based software solution for non-GLP preclinical study management. The acquisition of RockStep enables Instem to now provide an integrated solution of both Provantis ®, Instem's market-leading solution for GLP preclinical study management, and Climb. The combined solution will offer best-in-class GLP study management design with the flexibility to support non-GLP studies and will be the most comprehensive and advanced software for any type of facility engaged in preclinical research. This fusion of products and technologies expands the Instem solution suite to manage breeding, handling, moving, or genotyping animals, subject census management, study design, PK/PD analysis, pathology management, necropsy, study data visualization features, and more. 'At Instem, our mission is to help our customers make discoveries, and to accelerate and advance their research programs. The acquisition of RockStep and integration of Climb into our Provantis platform strengthens this commitment, enabling a fully connected, end-to-end environment that spans from early discovery through non-GLP and GLP study management to regulatory submission. By unifying these workflows under one provider, we help reduce risk, eliminate inefficiencies, and drive greater scientific and operational impact across the preclinical R&D lifecycle.' Vik Krishnan, CEO, Instem. The acquisition of RockStep adds many new large and industry-leading customers in the pharmaceutical and CRO spaces. Instem and RockStep together form the most experienced and talented team dedicated to the management and analysis of preclinical research data. The solution suite is significantly expanded to assemble a complete enterprise system for preclinical study management, tracking all aspects of breeding, census, veterinary procedures, study design and execution, including PK/PD analysis, along with data visualization and analytics. Climb offers a technologically advanced, flexible platform for non-GLP study designs and facilitates vivarium management, including animal health tracking and real-time alerts. This combined solution suite unifies teams and acts as a data hub, allowing scientists and lab staff to collaborate and communicate from anywhere. Large Pharma, Biotech, and CROs need flexibility and the ability to operate across different workstreams, studies, research types, and disease areas, which Instem is now able to offer through the combination of Provantis and Climb. About Instem Instem is a leading supplier of SaaS platforms across Discovery, Study Management, Regulatory Submission and Clinical Trial Analytics. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products. Founded in the United Kingdom in 1969, Instem has deep roots internationally across North America, EMEA and APAC. Instem maintains a commercial and technical presence throughout these regions, and we pride ourselves on localized support for our diverse client base. Learn more about Instem here: About RockStep Solutions, Inc. RockStep Solutions was founded in 2013 by Chuck Donnelly, a software engineer with experience working for life sciences companies, and Julie Morrison, a microbiology scientist. Since these early beginnings, RockStep has maintained a strong commitment to innovation, today partnering with Microsoft to integrate advanced technologies in the Azure cloud into our industry-leading Climb™ software. Launched in 2017, Climb has been adopted by a wide range of life sciences innovators – from global pharmaceutical companies and CROs to biotech organizations, government labs, a Nobel Laureate's lab at UCSF, and research labs at The Jackson Laboratory.
Epoch Times
2 hours ago
- Epoch Times
Diabetes Drug May Double the Risk of Diabetic Eye Disease in People Already at Risk
Tirzepatide, the popular diabetes drug sold as Mounjaro and Zepbound, more than doubles the risk of developing a severe, sight-threatening eye condition in patients who already have eye damage, according to a large study published recently in Diabetologia. The research found that 1.1 percent of tirzepatide users developed proliferative diabetic retinopathy (PDR)—a serious form of diabetic eye disease that can cause blindness—compared to just 0.5 percent of patients not taking the drug.
Business Insider
2 hours ago
- Business Insider
A woman lost 130 pounds after weight loss surgery. 4 simple habits have kept her in shape for 3 years.
At age 22, Emma Roma Jayne had no confidence. The content creator and TikTok strategist, based in Australia, told Business Insider that she was very active growing up, but an injury forced her to stop playing sports and she "started piling the weight on." In March 2022, Roma Jayne decided to get bariatric surgery: a weight-loss procedure to reduce the size of the stomach, meaning you can't eat as much and feel full faster. At the time, GLP-1 medications like Ozempic weren't on her radar. Roma Jayne complemented the surgery with therapy to treat her eating disorder. "Instead of working on my mental health, I would just binge and eat and get the dopamine from food," she said. To be eligible for the surgery, she had to commit to making serious, long-term lifestyle changes to prevent gaining the weight back, including having regular sessions with a nutritionist and a personal trainer for six months pre-surgery and two years after. "People think that it's like a 'lose weight quick' thing. And that's all you have to do and you'll be happy and everything will be solved, but your hunger does come back," Roma Jayne said of bariatric surgery. "If I had those bad habits, that lifestyle that I had before weight loss surgery, I would 100% gain my weight back." The data is mixed, but one a review of studies published in the journal Obesity Surgery found that up to 76% of patients regained a significant amount of weight six years after bariatric surgery. Reasons included the size of their stomach growing over time, inadequate support post-op, and patients struggling to break unhealthy habits. Following the advice of her nutritionist, Roma Jayne initially followed a high-protein, low-carb diet to lose weight, started working out six times a week, and lost 132 pounds over two years. Three years post-op, she's maintained her lower weight by mainly eating whole foods and being as active as possible. She has what she sees as a more balanced and sustainable approach to her diet and fitness routine. Roma Jayne, now 24, shared the four habits that she said have helped her stay in shape. 1) Eating mostly whole foods and the occasional treat As working out regularly and eating a healthy diet became habits for Roma Jayne, she became more interested in and passionate about nutrition. After the surgery, she ate small portions and few carbs to lose weight, but she no longer excludes any food group as her focus is long-term health. She still eats lots of protein as she learned that it helps her maintain her weight, but avoids ultra-processed foods and prioritizes whole foods, which are linked to better overall health. Roma Jayne said that she eats nutritious, balanced meals, such as homemade pizza and wholemeal wraps, around 90% of the time, but isn't scared of the occasional sweet treat. "If I want to have chocolate, I'll just have some chocolate. I don't restrict myself too much," she said. Roma Jayne's approach echoes what's known as the 80/20 rule, or eating healthily 80% of the time and being more flexible the remaining 20%. Dietitians have told BI that this is a sustainable way to eat and maintain your weight, because restrictive diets often lead to cravings, which make it harder to eat high calorie foods in moderation. 2) Strength training three times a week Roma Jayne lifts weights at the gym three or four times a week. Her current goal is to maintain her fat loss, while gaining muscle, which is known as body recomposition. Research suggests that strength training helps burn fat while also building muscle mass, which improves the metabolism. 3) Parking a little further from her destination In the past, Roma Jayne would go to the gym but struggled to be consistent as she saw it as a punishment for being overweight rather than a way to look after her health. Now she tries to stay as active as possible because it makes her feel good. Aside from her formal workouts, she's conscious of her step count and takes opportunities to walk during her day. For example, sometimes she parks a few minutes away from her office or goes for a walk on her lunch break. "Just any way to get out and about," she said. 4) Prioritizing healthy habits over the number on the scale Over the last few years, Roma Jayne's weight has fluctuated, but she makes an effort to be kind to herself when it does. She focuses more on sustaining the healthy habits she has established than worrying about the exact number on the scale, as she knows they count for more. "My weight fluctuates so much, and I think it's just I know that I'm exercising well, I'm eating well, I'm healthy. So as long as I know that I'm doing my best, what is on the scales just doesn't really matter," she said. Obesity experts agree that weight alone is not an accurate measure of a person's health. Other factors, such as how much muscle mass a person has and water retention, can increase the number on the scale. Plus, research suggests that where on the body the fat is located might have more bearing on a person's health than how much of it they have. "I think the biggest thing that's really helped me maintain these habits and maintain my weight loss is really just doing what's best for myself. And that's in every aspect of my life," Roma Jayne said.
